Spray-Dried Chitosan as a Direct Compression Tableting Excipient

REFERENCES

• S. A. Agnihotri, and T. M. Aminabhavi. (2007). Chitosan nanogranules for prolonged delivery of timolol maleate. Drug Dev. Ind. Pharm. 33:1254–1262.
   PubMed Web of Science ®Google Scholar
• T. J. Aspden, J. Adler, S. S. Davis, O. Skaugrud, and L. Illum. (1995). Chitosan as a nasal delivery system: Evaluation of the effect of chitosan on mucociliary clearance rate in the frog palate model. Int. J. Pharm. 122:69–78.
   Web of Science ®Google Scholar
• T. J. Aspden, J. D. T. Manson, N. Jones, J. Lowe, O. Skaugrud, and L. Illum. (1997). Chitosan as a nasal delivery system: The effect of chitosan on in vitro and in vivo mucociliary transport rates. J. Pharm. Sci. 86:509–513.
   PubMed Web of Science ®Google Scholar
• T. Aspden, L. Illum, and O. Skaugrud. (1996). Chitosan as a nasal delivery system: Evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models. Eur. J. Pharm. Sci. 4:23–31.
   Web of Science ®Google Scholar
• T. Aspden, L. Illum, and O. Skaugrud. (1997). The effect of chronic nasal application of chitosan solution on cilia beat frequency in Guinea pigs. Int. J. Pharm. 153:137–146.
   Web of Science ®Google Scholar
• P. Calvo, J. L. Vila-Jato, and M. J. Alonso. (1997). Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int. J. Pharm. 153:41–50.
   Web of Science ®Google Scholar
• D. O. Corrigan, A. M. Healy, and O. I. Corrigan. (2002). The effect of spray drying solutions of polyethylene glycol (PEG) and lactose/PEG on their physicochemical properties. Int. J. Pharm. 235:193–205.
   PubMed Web of Science ®Google Scholar
• O. Felt, P. Buri, and R. Gurny. (1998). Chitosan: A unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24:979–993.
   PubMed Web of Science ®Google Scholar
• J. J. Gerber, and A. P. Lotter. (1993). Compatibility study between propranolol hydrochloride and tablet excipients using differential scanning calorimetry. Drug Dev. Ind. Pharm. 19 (5):623–629.
   Web of Science ®Google Scholar
• P. He, S. S. Davis, and L. Illum. (1999). Chitosan microspheres prepared by spray drying. Int. J. Pharm. 187:53–65.
   PubMed Web of Science ®Google Scholar
• L. Illum. (1998). Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15:1326–1331.
   PubMed Web of Science ®Google Scholar
• J. Karlsen. (1991). Excipient properties of chitosan. Manuf. Chem. 62:18–19.
   Google Scholar
• J. Knapczyk. (1993). Excipient ability of chitosan for direct tableting. Int. J. Pharm. 89:1–7.
   Web of Science ®Google Scholar
• S. Kokil, P. Patil, K. Mahadik, and A. Paradkar. (2005). Studies on spray-dried mixtures of chitosan and hydrolyzed gelatin as tablet binder: A technical note. AAPS PharmSciTech. 6:E437–E443.
   PubMedGoogle Scholar
• A. F. Kotze, B. J. De Leeuw, H. L. LueBen, A. G. De Boer, J. C. Verhoef, and H. E. Juginger. (1997). Chitosan for enhanced delivery of therapeutic peptides across intestinal epithelia: In vitro evaluation in Caco-2 cell monolayers. Int. J. Pharm. 159:243–253.
   Web of Science ®Google Scholar
• J. G. LeHoux, and F. Grondin. (1993). Some effects of chitosan on liver function in the rat. Endocrinology 132:1078–1084.
   PubMed Web of Science ®Google Scholar
• K. Mladenovska, O. Cruaud, P. Richomme, E. Belamie, R. S. Raicki, M.-C. Venier-Julienne, E. Popovski, and K. Goracinova. (2007). 5-ASA loaded chitosan-Ca-alginate microparticles: Preparation and physicochemical characterization. Int. J. Pharm. 345:59–69.
   PubMed Web of Science ®Google Scholar
• J. Nunthanid, M. Laungtana-anan, P. Sriamornsak, S. Limmatvapirat, S. Puttipipatkhachorn, L. Y. Lim, and E. Khor. (2004). Characterization of chitosan acetate as a binder for sustained release tablets. J. Control. Release 99:15–26.
   PubMed Web of Science ®Google Scholar
• D. J. Ormrod, C. C. Holmes, and T. E. Miller. (1998). Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis 138:329–334.
   PubMed Web of Science ®Google Scholar
• P. R. Rege, R. J. Garmis, and L. H. Block. (2003). Spray-dried chitinosans. Part II: In vitro drug release from tablets made from spray-dried chitinosans. Int. J. Pharm. 252:53–59.
   PubMed Web of Science ®Google Scholar
• G. C. Ritthidej, P. Chomto, S. Pummangura, and P. Menasveta. (1994). Chitin and chitosan as disintegrants in paracetamol tablets. Drug Dev. Ind. Pharm. 20:2109–2134.
   Web of Science ®Google Scholar
• Y. Sawayanagi, N. Nambu, and T. Nagai. (1982a). Directly compressed tablets containing chitin or chitosan in addition to lactose or potato starch. Chem. Pharm. Bull. 30:2935–2940.
   PubMed Web of Science ®Google Scholar
• Y. Sawayanagi, N. Nambu, and T. Nagai. (1982b). Directly compressed tablets containing chitin or chitosan in addition to mannitol. Chem. Pharm. Bull. 30:4216–4218.
   PubMed Web of Science ®Google Scholar
• A. D. Sezer, and J. Akbuga. (1995). Controlled release of piroxicam from chitosan beads. Int. J. Pharm. 121:113–116.
   Web of Science ®Google Scholar
• H. Takeuchi, H. Yamamoto, T. Niwa, T. Hino, and Y. Kawashima. (1996). Enteral absorption of insulin in rats from mucoadhesive chitosan coated liposomes. Pharm. Res. 13:896–901.
   PubMed Web of Science ®Google Scholar
• H. Takeuchi, T. Yasuji, H. Yamamoto, and Y. Kawashima. (1999). Spray-dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry-coated tablet having a time-controlled releasing function. Pharm. Res. 17:94–99.
   Web of Science ®Google Scholar
• N. Tarimci, and D. Ermis. (1997). Sustained release characteristics and pharmacokinetic parameters of ketoprofen suppositories using chitosan. Int. J. Pharm. 147:71–77.
   Web of Science ®Google Scholar
• S. M. Upadrashta, P. R. Katikaneni, and N. O. Nuessle. (1992). Chitosan as a tablet binder. Drug Dev. Ind. Pharm. 18:2701–2708.
   Web of Science ®Google Scholar
• J. Wells. (2002). Pharmaceutical preformulation: The physicochemical properties of drug substances In M. E. Aulton. (Ed.), Pharmaceutics: The science of dosage form design ( pp. 133–134). New York: Churchill Livingstone.
   Google Scholar